| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $100K | — | — |
| R&D Expense | $3.3M | -24.0% | +70.7% |
| SG&A Expense | $5.1M | -1.0% | +71.9% |
| Operating Income | -$8.4M | +11.4% | -71.4% |
| Income Tax | $0 | — | — |
| Net Income | -$7.7M | +14.0% | -59.0% |
| EPS (Basic) | -$0.06 | +33.3% | +87.8% |
| EPS (Diluted) | -$0.06 | +33.3% | +87.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.6M | +66.1% | +860.5% |
| Accounts Receivable | $0 | — | — |
| Current Assets | $77.3M | +44.8% | +1174.8% |
| Total Assets | $85.8M | +33.3% | +349.3% |
| Current Liabilities | $6.5M | +10.2% | +20.5% |
| Total Liabilities | $8.3M | +5.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.0M | — | — |
| Capital Expenditures | $559K | — | — |
| Investing Cash Flow | -$27.6M | — | — |
| Financing Cash Flow | $83.6M | — | — |
| Free Cash Flow | -$17.5M | — | — |
| +7.4% |
| Stockholders' Equity | $77.5M | +37.1% | +581.3% |